Lv3
250 积分 2025-07-05 加入
Phase II Study of Pembrolizumab Plus Capecitabine and Bevacizumab for Microsatellite Stable/Mismatch Repair-Proficient Metastatic Colorectal Cancer
3天前
待确认
Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 study
4天前
已完结
Lipids guide T cell antitumor immunity by shaping their metabolic and functional fitness
1个月前
已完结
The immune microenvironment of colorectal cancer
1个月前
已完结
Cancer incidence and mortality in China, 2022
1个月前
已完结
Myeloid-derived suppressor cells and regulatory T cells in colorectal cancer: a synergistic immunosuppressive axis and emerging therapeutic opportunities
1个月前
已完结
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
1个月前
已完结
Colorectal cancer immunotherapy-Recent progress and future directions
1个月前
已完结
Decoding subclonal anti-tumor immunity
1个月前
已完结
皖公网安备34019202002308
